PE-Backed Therapure Biopharma Delays $93M Canadian IPO
By Matthew Perlman ( February 5, 2016, 7:04 PM EST) -- Private equity-backed biopharmaceutical company Therapure Biopharma said Thursday that it has postponed plans for a CA$130 million ($93.5 million) initial public offering in Canada because of shaky markets in the country and in the U.S....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.